Madeline Bartsch

Ms. Madeline Bartsch

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2025 in The Journal of Nutrition
Verified
Journal Article
Open access
MBMadeline Bartsch
Madeline Bartsch
MVMarius Vital
Marius Vital
SWSabrina Woltemate
Sabrina Woltemate
FBFreek G Bouwman
Freek G Bouwman
SBShoma B Berkemeyer
Shoma B Berkemeyer
MMMattea Müller
Mattea Müller
Dietary fiber supports metabolic health via microbial fermentation, producing short-chain fatty acids (SCFAs). However, metabolic responses to fiber vary between individuals, potentially due to differences in gut microbiota composition. The Prevotella-to-Bacteroides (P/B) ratio has emerged as a potential biomarker for fiber responsiveness. This study examined how stratified fiber supplementation affects microbial and metabolic outcomes in individuals with Prevotella- or Bacteroides-dominated microbiota. In this single-blinded, randomized cross-over study, 23 healthy adults were classified as P-type (≥10% Prevotella) or B-type (≥10% Bacteroides) via 16S rRNA sequencing. Participants consumed 15 g/day of arabinoxylan (AX), inulin (INU), or placebo (PLA) for one week each, with 2-week washouts. After each phase, fasting and postprandial plasma SCFAs, branched-chain fatty acids (BCFAs), breath hydrogen, glucose, insulin, PYY, cholesterol, appetite ratings, and fecal microbiota were assessed. Data were analyzed using repeated measures ANOVA, Friedman test, and multivariate microbiome analysis. In P-types, AX increased fasting propionate vs. PLA (p = 0.04). In B-types, AX increased fasting propionate vs. INU (p = 0.02) and tended to elevate postprandial propionate vs. PLA in the first 60 minutes after breakfast (p = 0.05). AX also increased postprandial acetate vs. PLA in B-types (p = 0.04). INU reduced fasting BCFAs in B-types (p < 0.05) but did not increase SCFAs. Breath hydrogen varied widely in B-types after INU but not in P-types. Neither fiber affected glucose, insulin, or PYY. AX reduced appetite ratings in P-types (p < 0.05). INU increased Anaerostipes and Bifidobacterium and reduced Phocaeicola in both groups (q < 0.25). AX increased Fusicatenibacter in B-types (q = 0.18) and Paraprevotella in P-types (q = 0.17). B-types exhibited fiber-specific shifts in SCFA and BCFA metabolism and breath hydrogen, whereas P-types displayed a more limited overall response, with fewer metabolic and microbial parameter affected. These findings highlight the complexity of diet-microbiota interactions and support the potential relevance for microbiota-based nutrition strategies. German Register of Clinical Studies (DRKS00028898).

31 July 2025 in Chronobiology International
Verified
Journal Article
Open access
MRMariana Romanenko
Mariana Romanenko
MBMadeline Bartsch
Madeline Bartsch
LPLiubov Piven
Liubov Piven
Andreas HahnAndreas Hahn
Andreas Hahn
MMMattea Müller
Mattea Müller
Circadian disruption, arising from behaviors such as shift work and sleep deprivation, is increasingly prevalent and associated with metabolic disorders, including obesity, type 2 diabetes, and cardiovascular disease. The gut microbiome plays a crucial role in metabolic homeostasis by producing metabolites - such as short-chain fatty acids, secondary bile acids, and microbial-associated molecular patterns - that influence nutrient absorption, immune responses, and host metabolism in alignment with circadian rhythms. This review explores how circadian disruptors influence the human gut microbiome, focusing on changes in microbial composition, diversity, and functionality, and their implications for metabolic health. Preclinical studies demonstrate that circadian disruptions alter microbial composition, reduce rhythmicity, and impair functionality, contributing to metabolic disorders. However, human studies often report inconsistent findings, with microbial functionality appearing more sensitive to disruptions than composition. Eating patterns affect both the gut microbiome and circadian alignment; their optimization could realign microbial and host rhythms to promote metabolic homeostasis. Future research should focus on longitudinal and interventional studies using advanced methodologies, such as real-time intestinal gas measurements, to capture dynamic microbial activity in humans. Understanding microbial responses to circadian disruptors could inform therapeutic strategies targeting host-microbe interactions to improve metabolic health.

20 January 2026 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
MBMadeline Bartsch
Madeline Bartsch
LHLinda Hemmelrath
Linda Hemmelrath
FKFelix Kerlikowsky
Felix Kerlikowsky
ABAnja Bruns
Anja Bruns
MBMilena Burhop
Milena Burhop
MMMattea Müller
Mattea Müller
Background: Diet is a determinant of metabolic health, partly through its effects on the gut microbiome, which influences nutrient metabolism, inflammation, and energy balance. We investigated the mediating role of gut microbiome features in the association between dietary quality and metabolic risk. Methods: In this cross-sectional study, we included 269 adults aged 25–76 years with heterogeneous metabolic profiles, BMI ranging from 17.5 to 47.6 kg/m², and fasting glucose levels between 5.6 and 6.9 mmol/L. Dietary quality was assessed using the Healthy Eating Index (HEI-MON), the Planetary Health Diet Index (PHEI-MON), and the alternate Mediterranean Diet Score (aMED), derived from food-frequency questionnaires and three-day food records. Metabolic risk was quantified using a continuous metabolic syndrome score (cMetS) incorporating waist circumference, mean arterial pressure, HDL cholesterol, triglycerides, and fasting glucose. Microbiome composition (16 S rRNA gene sequencing) and predicted SCFA pathways were analyzed using adjusted multiple linear regression, PERMANOVA, and differential abundance analysis. Mediation analyses examined microbial features as potential mediators of the association between diet and metabolic risk. Results: Higher HEI-MON, PHEI-MON, and aMED were associated with lower cMetS ( q < 0.01). Christensenellaceae R7 group and Ruminococcaceae NK4A214 group were enriched with higher dietary quality and lower cMetS ( q < 0.1), whereas Lachnoclostridium were associated with lower diet quality and higher cMetS ( q < 0.1). The Enterotype Dysbiosis Score (EDS) correlated inversely with dietary quality (PHEI-MON q = 0.04) and positively with cMetS ( q = 0.04). Butyrate-synthesis pathways were more abundant in individuals with higher dietary quality ( q < 0.05) and inversely associated with cMetS ( q < 0.05). Mediation analysis indicated that the Ruminococcaceae NK4A214 group , the Christensenellaceae R7 group , and Lachnoclostridium accounted for up to 16% of the association between diet and metabolic risk. Conclusion: Better dietary quality is associated with lower metabolic risk and positive gut microbiome signatures across taxonomic, functional, and stability-related aspects. Certain taxa statistically mediated these associations, highlighting gut microbiome features that may contribute to observed links between dietary patterns and metabolic health. Graphical

23 March 2025 in Marine Drugs
Verified
Journal Article
Open access
PDF file
FKFelix Kerlikowsky
Felix Kerlikowsky
MBMadeline Bartsch
Madeline Bartsch
WJWiebke Jonas
Wiebke Jonas
Andreas HahnAndreas Hahn
Andreas Hahn
JSJan Philipp Schuchardt
Jan Philipp Schuchardt
Obesity increases the risk for insulin resistance (IR) and type-2 diabetes. Lifestyle interventions (LI) and dietary supplementation can help mitigate IR. We investigated the effect of calanus oil (CO) supplementation, combined with LI, on glucose homeostasis in obese subjects. CO, a novel marine oil, contains omega-3 fatty acid wax esters as well as plant sterols and astaxanthin. In the double-blind, randomized, placebo-controlled 12-week intervention study, 266 subjects with distinct IR phenotypes were assigned to four groups: 2 g CO/day, 4 g CO/day, 2 g CO/day + LI, and placebo. The effect of CO on HOMA index reduction was influenced by the initial (t0) squared HOMA index (interaction p = 0.011). A post hoc test showed significant improvement with 2 g CO/day + LI (estimated marginal means [EMM] 95% confidence interval [CI]: −0.19 [−0.80–0.41], p = 0.021). Secondary analysis revealed that 4 g CO/day had significant effects in subjects with mild IR (HOMA index 2.5–5.0) (EMM [95% CI]: −0.76 [−1.53–0.03], p = 0.043). CO supplementation improved glucose homeostasis, with effects varying by dose, combination with LI, and IR phenotype.

1 September 2025
Verified
Journal Article
Open access
PDF file
NKNataliya Kharchenko
Nataliya Kharchenko
MRMaryana Romanenko
Maryana Romanenko
LPLyubov Piven
Lyubov Piven
LSLyudmila Syneok
Lyudmila Syneok
AHAnna Havalko
Anna Havalko
MMMattea Müller
Mattea Müller
Current evidence demonstrates that the gut microbiome has its own rhythmicity and plays an important role in regulating the functional rhythms of the gastrointestinal tract as well as in aligning peripheral circadian clocks with sleep–wake and light–dark cycles. Preclinical studies indicate that the loss of microbiota rhythmicity may contribute to the development of metabolic disorders. Factors such as genetic mutations in the circadian clock, jet lag, total sleep deprivation and high-fat diets are associated with reduced microbiota diversity, decreased abundance of short-chain fatty acid–producing bacteria, partial loss of microbial rhythmicity, and alterations in functional activity. Notably, in some cases functional activity appears to be more sensitive to circadian desynchronization than composition or diversity. This opens prospects for new diagnostic and therapeutic strategies, however, it remains unclear to what extent preclinical findings can be extrapolated to clinical practice. Further controlled clinical studies are needed to elucidate the mechanisms underlying the interactions between the microbiome, circadian rhythms, and human metabolic health.

1 July 2025 in Nutrition and Healthy Aging
Verified
Journal Article
Open access
MBMadeline Bartsch
Madeline Bartsch
FKFelix Kerlikowksy
Felix Kerlikowksy
AHAndreas Hahn
Andreas Hahn
SBShoma Berkemeyer
Shoma Berkemeyer
SWSabrina Woltemate
Sabrina Woltemate
MMMattea Müller
Mattea Müller
Background: With increasing life expectancy, dietary choices are crucial for healthy aging. Objective: This study investigates associations between two dietary indices, the energy-adjusted Dietary Inflammatory Index (E-DII) and the healthful Plant-based Diet Index (hPDI), and biomarkers related to metabolic health and micronutrient status, focusing on the mediating role of gut microbiota. Methods: We conducted a secondary, exploratory analysis of baseline data from 129 community-based participants aged ≥70 years (median age: 75 years). Dietary indices were calculated from 3-day food protocols, and biomarkers were measured in blood samples. Cognitive and physical function were assessed using validated questionnaires, body composition was determined via bioimpedance, and fecal gut microbiota composition through 16S rRNA gene sequencing. Statistical analyses included multiple linear regression models, Permutational Multivariate Analysis of Variance, and mediation analysis. Results: We found no significant associations between the indices and gut microbiota diversity. However, red blood cell (RBC) folate and serum uric acid were significantly associated with E-DII (stand. β = −0.32 and 0.23, respectively, p < 0.01 and 0.01) and contributed to microbiota composition variance (R 2 = 0.01, Q = 0.21). Specific genera correlated with serum uric acid ( Oscillibacter : coefficient = −0.01, Q = 0.24, Gemmiger : coefficient = −0.02, Q = 0.23) and RBC folate ( Bacteroides : coefficient = 0.03, Q = 0.22), independent of dietary patterns. Conclusions: This study suggests that gut microbiota composition does not mediate the associations between a healthy plant-based or anti-inflammatory diet and metabolic health markers in a healthy, older population. However, microbial genera were associated with uric acid and folate concentrations independent of the investigated dietary patterns, indicating potential roles in folate and uric acid metabolism.